LOX-PP can decelerate Her-2/neu-driven tumor growth in the cancer xenograft model of nude mice by inhibiting AKT, ERK1/2, NF-κB activation, and epithelial–mesenchymal transition (EMT) [22]. The gene discussed is NFKB1; the disease is neoplasm.